Glycycoumarin Induces G2/M Cell Cycle Arrest and Apoptosis in Non-Small-Cell Lung Cancer Cells via Suppressing the PI3K/AKT/mTOR/HIF-1α Pathway
Current Pharmaceutical Design · Published 2026-06-16 · DOI 10.2174/0113816128473617260609100900
Authors (7)
Yinglin Guo, Xinyu Wu, Pengying Liang, Xuhong Li, Wenhong Zhou, Zuqiang Wu, Linhu Ye
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Guo, Y., Wu, X., Liang, P., et al. (2026). Glycycoumarin Induces G2/M Cell Cycle Arrest and Apoptosis in Non-Small-Cell Lung Cancer Cells via Suppressing the PI3K/AKT/mTOR/HIF-1α Pathway. Current Pharmaceutical Design. https://doi.org/10.2174/0113816128473617260609100900
Related articles
- Exploring the Potential of Dendrimers in Skin Drug Delivery: Applications andAdvances · Current Pharmaceutical Design · 2026 · Same journal
- Discovery of Anti-Japanese Encephalitis Compounds: Based on Natural CompoundLibrary, Bioinformatics, Network Pharmacology and Experimental Validation · Current Pharmaceutical Design · 2026 · Same journal
- Computational Insights into 1,4-Naphthoquinones as Allosteric MEK1 Inhibitors for Cancer Therapy · Current Pharmaceutical Design · 2026 · Same journal
- Combining Network Pharmacology, Machine Learning, Molecular Docking, andExperimental Validation to Explore the Mechanism of Danggui-Shaoyao-San intreating Rheumatoid arthritis · Current Pharmaceutical Design · 2026 · Same journal
- Receptor for Advanced Glycation End Products (RAGE) Ligand Axis as a Mediatorof Inflammation and Oxidative Stress in Cancer: Implications for CancerProgression and Therapeutic Targeting · Current Pharmaceutical Design · 2026 · Same journal
- Leveraging Untargeted Metabolomics and Molecular Dynamics SimulationUnraveling the Multi-Target Mechanism of Taohong Siwu Decoction againstPulmonary Hypertension · Current Pharmaceutical Design · 2026 · Same journal
- Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing MedicalDevice-Assisted Diagnosis · Current Pharmaceutical Design · 2026 · Same journal
- Polyphenols in Cancer Therapy: Recent Advances, Mechanistic Pathways, and Therapeutic Insights · Current Pharmaceutical Design · 2026 · Same journal
- Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, andRecent Innovations · Current Pharmaceutical Design · 2026 · Same journal
- Formulation, Characterization, and Preliminary In Vitro Evaluation of LetrozoleIncorporated Eudragit® RS 100 Nanoparticles Using HepG2 Cells · Current Pharmaceutical Design · 2026 · Same journal